← FDA Drug Approvals (Drugs@FDA)

XEGLYZE

NDA · New Drug Application · Sponsor: LNHC · Approved 2020-07-24

Drug application

FDA Application #

NDA206966

Application type

New Drug Application

Brand name

XEGLYZE

Generic name

Abametapir

Active ingredients

ABAMETAPIR

Dosage form

LOTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

LNHC

First approval

2020-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown